Navigation Links
Genetics Society of America selects 5 geneticists to receive society's 2014 Awards
Date:1/29/2014

of genetics in the last 15 years. Recipients of the GSA Medal are recognized for elegant and highly-meaningful contributions to modern genetics, and exemplify the ingenuity of GSA membership.

Recipient: Frederick M. Ausubel, PhD, Harvard Medical School and Massachusetts General Hospital
Award: Thomas Hunt Morgan Medal

Dr. Ausubel is Professor of Genetics, Department of Genetics at Harvard Medical School, and is the Karl Winnacker Distinguished Investigator in the Department of Molecular Biology at Massachusetts General Hospital.

During his 40-year career, Dr. Ausubel's work has centered on host-microbe interactions and host innate immunity. He is widely recognized as a key scientist responsible for establishing the modern post-recombinant DNA field of host-microbe interactions using simple non-vertebrate hosts. He has used genetic approaches to conduct pioneering work that spawned six related areas of research: the evolution and regulation of Rhizobium genes involved in symbiotic nitrogen fixation; the regulation of Rhizobium genes by two-component regulatory systems involving histidine kinases; establishing Arabidopsis thaliana as a world-wide model system; identifying a large family of plant disease resistance genes; identifying so-called multi-host bacterial pathogens; and demonstrating that Caenorhabditis elegans has an evolutionarily conserved innate immune system that shares features of both plant and mammalian immunity.

His early work with Klebsiella pneumonia and Rhizobium meliloti brought discoveries about key regulatory networks in free-living and symbiotic nitrogen fixing bacteria and the genes that symbiotic bacteria use to interact with their hosts. He also applied genetic analysis to the host side of microbial plant and microbial animal interactions, using Arabidopsis and C. elegans to define fundamental immune defense mechanisms, ultimatel
'/>"/>

Contact: Adam P. Fagen
afagen@genetics-gsa.org
301-634-7300
Genetics Society of America
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Epigenetics and epidemiology -- hip, hype and science
2. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
3. Not by DNA alone: How the epigenetics revolution is fostering new medicines
4. Study finds voter genetics may predict election outcomes
5. The Genetics Society of America announces DeLill Nasser Travel Award recipients
6. MARC travel award announced for the 2012 GSA Yeast Genetics and Molecular Biology Meeting
7. $500,000 Gruber Foundation Genetics Prize goes to Philadelphia scientist
8. Dr. Douglas Wallace to receive Gruber Foundation 2012 Genetics Prize
9. Genetics Society of Americas Genetics journal highlights for July 2012
10. New study announced that will use genetics to test for Alzheimers risk
11. Sick from stress? Blame your mom… and epigenetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2015)... 18, 2015  Cepheid (NASDAQ: CPHD ) today ... conferences, and invited investors to participate via webcast. , ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern ... Orlando, FL Wednesday, March 4, 2015 at 10.25 ... the live webcasts for these events, please visit Cepheid,s website ...
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting ... company and has launched a new marketing campaign to ... Organization (CLO).  The new campaign focuses on First ... protocol and shipments. The first headline in ... aligns Marken,s priorities with its client,s priorities. Marken recognizes ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... day of competition in London, a team of four ... emerged as the winners of this year,s Biotechnology Young ... Biotechnology Young Entrepreneurs Scheme (YES) competition are Ben Owens, ... University of Oxford. The team pitched their ...
... Stem cell scientists at King,s College London will today ... UK Stem Cell Bank (UKSCB) their first clinical grade ... from animal-derived products, known as ,xeno-free, stem cells. ... ,gold standard, lines for developing new stem cell-based therapies, ...
... Darrel Tremaine has been known to go to extremes for ... through a dark, muddy limestone cave in Northwest Florida to ... His goal? To compare ancient meteorological patterns with modern ones ... policymakers on how to build a sustainable water supply. ...
Cached Biology News:Winning early-career researchers excel in entrepreneurship 2Winning early-career researchers excel in entrepreneurship 3Stem cell research in the UK reaches significant milestone 2Stem cell research in the UK reaches significant milestone 3Stem cell research in the UK reaches significant milestone 4Researcher finds key to ancient weather patterns in Florida's caves 2Researcher finds key to ancient weather patterns in Florida's caves 3Researcher finds key to ancient weather patterns in Florida's caves 4
(Date:2/27/2015)... , Feb. 27, 2015 Bionomics Limited (ASX:BNO, ... DisrupTOR-1 trial of BNC105 in patients with metastatic renal ... Orlando, Florida . The data will be ... City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and IL-8 as ...
(Date:2/27/2015)... South San Francisco, CA (PRWEB) February 27, 2015 ... it is joining forces on February 28 with patients ... globally to raise awareness for Rare Disease Day®. ... of rare diseases and calling attention to the special ... support community around them. , “Cytokinetics is proud to ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital IQ ... Stock Report coverage on MabVax Therapeutics Holdings Inc . ... a clinical stage biotechnology company focused on the development ... needs in the treatment of cancer. MabVax has discovered ... the protective immune responses generated by patients who have ...
(Date:2/26/2015)... TORONTO , Feb. 26, 2015 /PRNewswire/ - SQI ... SQIDF), a life sciences company that develops and commercializes ... reported its financial and operational results for the fiscal ... this press release are in Canadian dollars (CAD), unless ... Company continued to win new business from our existing ...
Breaking Biology Technology:New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
... Company Posts Fourth Quarter EPS of $0.37, Up 16% -, - For ... Up 41%; Total Revenues and Product ... Income Growth in Four Years, ... $1.72 -, SAN DIEGO, Feb. 13 Gen-Probe Incorporated,(Nasdaq: GPRO ...
... Inverness Medical,Innovations (Amex: IMA ) today announced ... was successfully completed on February 12,2008. BBI, located ... manufacture of non-invasive lateral flow tests and has ... reagents. The,final purchase price consisted of cash of ...
... 13 The following statement,is attributable to Kathy ... Control and Epidemiology (APIC):, "APIC is concerned ... as high as 70 percent according to recent ... strain, provide evidence that,the very nature of these ...
Cached Biology Technology:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 2Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 3Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 4Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 5Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 6Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 7Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 8Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 9Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 10Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 11Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 12Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 13Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 14Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 15Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 16APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs) 2